C.R. Bard Put Profits Ahead of Patients' Safety, Lawyer Says
8/14/2013 7:55:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
C.R. Bard Inc. (BCR) officials put profits ahead of women’s safety when they ignored warnings about defects in some vaginal-mesh implants, a lawyer told a jury in the first federal trial of claims over the devices. Bard officials knew the company was making implants for shoring up pelvic muscles out of plastic that carried a warning that it shouldn’t be permanently implanted in humans, and still pushed ahead with production, Henry Garrard, a lawyer for a woman suing over the devices, said in closing arguments today in Charleston, West Virginia. “We’ve got a company here that steamrolled through safety principles,” Garrard told jurors.
Help employers find you! Check out all the jobs and post your resume.